The purpose of this study is to describe the perception of neuraminidase inhibitors (NAIs) during the pandemic A(H1N1)2009 influenza among general practitioners. A survey was conducted between 15 July and 15 September 2010 among a random sample of metropolitan French GPs. Among the 161 respondents, only 6% reported that they "often" prescribed NAIs during the pandemic A(H1N1)2009 influenza, while 69% reported that they prescribed NAIs "from time to time". The main objectives of GPs were to limit the risk of complications and the duration of symptoms. The main predictor of prescription of neuraminidase inhibitors during the pandemic A(H1N1)2009 influenza was the prescription of NAIs during epidemic seasonal periods (OR = 3.23 [95% CI 1.3 to 8.8]). Barriers to the prescription of NAIs were an estimated lack of efficacy (64%) and a negative benefit/risk balance (52%). Among the GPs surveyed in this research, 62% reported that they had been vaccinated against influenza A(H1N1)2009, while 73% recommended vaccination. GPs who prescribed NAIs during the pandemic A(H1N1)2009 influenza were those who prescribed NAIs during a seasonal influenza epidemic. To improve the outpatient prescription of NAIs during pandemic outbreaks, more knowledge about NAIs is required during seasonal influenza.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Possible bidirectional human-swine and subsequent human-human transmission of influenza virus A(H1N1)/2009 in Japan.
Zoonoses Public Health
September 2022
Avian Zoonosis Research Center, Faculty of Agriculture, Tottori University, Tottori, Japan.
In 2019, sows at a swine farm in Japan showed influenza-like illness (ILI) shortly after contact with an employee that exhibited ILI. Subsequently, a veterinarian became sick shortly after examining the sows and was diagnosed with influenza A virus (IAV) infection. Then, her family also contracted the infection.
View Article and Find Full Text PDFPandemic lineage 2009 H1N1 influenza A virus infection in farmed mink in Utah.
J Vet Diagn Invest
January 2022
Utah Veterinary Diagnostic Laboratory, School of Veterinary Medicine, Department of Animal, Dairy and Veterinary Science, Utah State University, Logan and Spanish Fork, UT, USA.
Mink are susceptible to infection with influenza A virus (IAV) of swine and human origin. In 2019, a Utah mink farm had an outbreak of respiratory disease in kits caused by infection with the pandemic influenza A(H1N1)2009 virus [A(H1N1)pdm09]. In 3 wk, ~325, 1-2-wk-old kits died (10% mortality in kits).
View Article and Find Full Text PDFFor several decades, the World Health Organization has collected, maintained, and distributed invaluable country-specific disease surveillance data that allow experts to develop new analytical tools for disease tracking and forecasting. To capture the extent of available data within these sources, we proposed a completeness metric based on the effective time series length. Using FluNet records for 29 Pan-American countries from 2005 to 2019, we explored whether completeness was associated with health expenditure indicators adjusting for surveillance system heterogeneity.
View Article and Find Full Text PDFHost Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition.
Vaccines (Basel)
October 2020
School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Among the four genera of influenza viruses (IVs) and the four genera of coronaviruses (CoVs), zoonotic αIV and βCoV have occasionally caused airborne epidemic outbreaks in humans, who are immunologically naïve, and the outbreaks have resulted in high fatality rates as well as social and economic disruption and losses. The most devasting influenza A virus (IAV) in αIV, pandemic H1N1 in 1918, which caused at least 40 million deaths from about 500 million cases of infection, was the first recorded emergence of IAVs in humans. Usually, a novel human-adapted virus replaces the preexisting human-adapted virus.
View Article and Find Full Text PDFReassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
PLoS Med
September 2020
Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, England.
Background: Early studies of narcolepsy after AS03-adjuvanted pandemic A/H1N12009 vaccine (Pandemrix) could not define the duration of elevated risk post-vaccination nor the risk in children aged under 5 years who may not present until much older.
Methods/findings: Clinical information and sleep test results, extracted from hospital notes at 3 large pediatric sleep centers in England between September 2017 and June 2018 for narcolepsy cases aged 4-19 years with symptom onset since January 2009, were reviewed by an expert panel to confirm the diagnosis. Vaccination histories were independently obtained from general practitioners (GPs).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!